MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

Phase 3
Completed
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
364
Registration Number
NCT00001013
Locations
πŸ‡ΊπŸ‡Έ

Tulane Univ School of Medicine, New Orleans, Louisiana, United States

πŸ‡ΊπŸ‡Έ

Charity Hosp / Tulane Univ Med School, New Orleans, Louisiana, United States

πŸ‡ΊπŸ‡Έ

SUNY / State Univ of New York, Syracuse, New York, United States

and more 20 locations

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
240
Registration Number
NCT00001083
Locations
πŸ‡ΊπŸ‡Έ

Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Univ of Miami (Pediatric), Miami, Florida, United States

πŸ‡ΊπŸ‡Έ

North Shore Univ Hosp, Great Neck, New York, United States

and more 58 locations

Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
20
Registration Number
NCT00000728
Locations
πŸ‡ΊπŸ‡Έ

Stanford Univ School of Medicine, Stanford, California, United States

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
92
Registration Number
NCT00006066
Locations
πŸ‡ΊπŸ‡Έ

Nyu Ny Nichd Crs, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Children's National Med. Ctr. Washington DC NICHD CRS, Washington, District of Columbia, United States

πŸ‡ΊπŸ‡Έ

Usc La Nichd Crs, Los Angeles, California, United States

and more 11 locations

A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children

Phase 3
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-02
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
819
Registration Number
NCT00000637
Locations
πŸ‡ΊπŸ‡Έ

Children's Med Ctr of Dallas, Dallas, Texas, United States

πŸ‡ΊπŸ‡Έ

Univ of Maryland at Baltimore / Univ Med Ctr, Baltimore, Maryland, United States

πŸ‡ΊπŸ‡Έ

UCLA Med Ctr / Pediatric, Los Angeles, California, United States

and more 77 locations

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
6
Registration Number
NCT00001108
Locations
πŸ‡ΊπŸ‡Έ

Cook County Hosp, Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

Univ of Massachusetts Med School, Worcester, Massachusetts, United States

πŸ‡ΊπŸ‡Έ

Univ of Mississippi Med Ctr, Jackson, Mississippi, United States

and more 16 locations

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
85
Registration Number
NCT00000721
Locations
πŸ‡ΊπŸ‡Έ

Stanford CRS, Palo Alto, California, United States

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
64
Registration Number
NCT00000743
Locations
πŸ‡ΊπŸ‡Έ

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans, Louisiana, United States

πŸ‡ΊπŸ‡Έ

UCLA CARE Center CRS, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States

and more 1 locations

A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection

Phase 3
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
400
Registration Number
NCT00000750
Locations
πŸ‡ΊπŸ‡Έ

UCLA Med Ctr / Pediatric, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Univ of Illinois College of Medicine / Pediatrics, Chicago, Illinois, United States

and more 39 locations

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
94
Registration Number
NCT00001085
Locations
πŸ‡ΊπŸ‡Έ

The Ponce de Leon Ctr. CRS, Atlanta, Georgia, United States

πŸ‡ΊπŸ‡Έ

Rush Univ. Med. Ctr. ACTG CRS, Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

Cook County Hosp. CORE Ctr., Chicago, Illinois, United States

and more 12 locations
Β© Copyright 2025. All Rights Reserved by MedPath